MedTrace Logo

Stripping Massage on Rhomboid Major and Minor Active Trigger Points in Upper Thoracic Pain

NCT06556758 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2024-08-16

No results posted yet for this study

Summary

Aim of this randomized controlled trial is to see the effects of stripping massage on rhomboids major and minor active trigger points in patients with upper thoracic pain for reducing pain, enhancing thoracic range of motion and physical functioning

Conditions

  • Upper Thoracic Pain Due to Active Trigger Points

Interventions

OTHER

stripping massage + conventional therapy

Stripping massage on rhomboid major and minor active trigger point in the direction of muscle fiber from origin to insertion of muscle. Frequency: 3 minutes for 3 times/week for 4 consecutive weeks. Conventional PT including Hot pack for 10 minutes + ischemic compression for 90 secs + CPA glides grade 3 kaltenborn mobilization on thoracic T1 to T4 (5 reps x 1 set) Frequency: 3 times/ week for 4 weeks

OTHER

Conventional therapy

conventional therapy including Hot pack for 10 minutes + ischemic compression for 90 secs + CPA glides grade 3 kaltenborn mobilization on thoracic T1 to T4 (5 reps x 1 set ) Frequency : 3 times/ week for 4 weeks

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Madiha Ali, MSOMPT · Riphah International University

  • Aqsa Mustafa, MSompt* · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-09
Primary Completion
2024-12-30
Completion
2025-01-10

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06556758 on ClinicalTrials.gov